- Home
- EYPT vs ETWO Comparison
EYPT vs ETWO Comparison
Compare EYPT & ETWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- ETWO
- Stock Information
- Founded
- EYPT 1987
- ETWO 2000
- Country
- EYPT United States
- ETWO United States
- Employees
- EYPT N/A
- ETWO N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- ETWO EDP Services
- Sector
- EYPT Industrials
- ETWO Technology
- Exchange
- EYPT Nasdaq
- ETWO Nasdaq
- Market Cap
- EYPT 579.4M
- ETWO 663.4M
- IPO Year
- EYPT 2005
- ETWO N/A
- Fundamental
- Price
- EYPT $9.65
- ETWO $3.24
- Analyst Decision
- EYPT Strong Buy
- ETWO Sell
- Analyst Count
- EYPT 8
- ETWO 4
- Target Price
- EYPT $24.75
- ETWO $2.78
- AVG Volume (30 Days)
- EYPT 841.7K
- ETWO 3.5M
- Earning Date
- EYPT 08-06-2025
- ETWO 07-10-2025
- Dividend Yield
- EYPT N/A
- ETWO N/A
- EPS Growth
- EYPT N/A
- ETWO N/A
- EPS
- EYPT N/A
- ETWO N/A
- Revenue
- EYPT $56,042,000.00
- ETWO $607,688,000.00
- Revenue This Year
- EYPT N/A
- ETWO $1.84
- Revenue Next Year
- EYPT N/A
- ETWO $2.32
- P/E Ratio
- EYPT N/A
- ETWO N/A
- Revenue Growth
- EYPT 12.04
- ETWO N/A
- 52 Week Low
- EYPT $3.91
- ETWO $1.75
- 52 Week High
- EYPT $13.99
- ETWO $4.82
- Technical
- Relative Strength Index (RSI)
- EYPT 61.83
- ETWO 69.20
- Support Level
- EYPT $8.96
- ETWO $3.21
- Resistance Level
- EYPT $10.77
- ETWO $3.24
- Average True Range (ATR)
- EYPT 0.74
- ETWO 0.01
- MACD
- EYPT -0.02
- ETWO -0.03
- Stochastic Oscillator
- EYPT 60.25
- ETWO 100.00
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.